US 9187746
Dual targeting siRNA agents
granted A61KA61K31/713
Quick answer
US patent 9187746 (Dual targeting siRNA agents) held by Alnylam Pharmaceuticals, Inc. expires Mon Nov 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Nov 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/713